search
Back to results

Effects of a Supplement on Acute Respiratory Infections

Primary Purpose

Respiratory Tract Infection

Status
Completed
Phase
Not Applicable
Locations
Mexico
Study Type
Interventional
Intervention
Omniplus Supreme
Placebo
Sponsored by
Omnilife Manufactura, SA de CV
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Respiratory Tract Infection focused on measuring Respiratory tract infection, Incidence, Dietary supplements, Micronutrients, Plant extracts

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy adult subjects (without active respiratory infections, or without diseases that compromise immune system)
  • Who presented no abnormalities in their laboratory tests (active infections, immunosuppression, renal or hepatic impairment)
  • Who did not take drugs that affect the immune system (anti-inflammatory drugs, antibiotics, steroids).

Exclusion Criteria:

  • Subjects with active acute respiratory infections.
  • Subjects with chronic respiratory disease requiring treatment other than bronchodilators at the time of assessment.
  • Subjects with diseases affecting the immune system (autoimmune illness, diabetes, etc.)
  • Pregnant women or currently nursing.
  • Subjects with cardiovascular disorders (uncontrolled hypertension) or neurological disorders (epilepsy).
  • Subjects with allergies to any components of the products.
  • Subjects with low treatment adherence (less than 80%).

Sites / Locations

  • Omnilife

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Experimental

Arm Label

Placebo

Omniplus Supreme

Arm Description

Two envelopes of the product in 240 ml of water in a disposable cup, 90 days of actual consumption.

Two envelopes of the product in 240 ml of water in a disposable cup, 90 days of actual consumption.

Outcomes

Primary Outcome Measures

Incidence of acute respiratory infections
Number of subjects with at least one episode of acute respiratory infection according to supplementation group.

Secondary Outcome Measures

Mean episodes of acute respiratory infections
Mean episodes of acute respiratory infections by supplementation group
Mean duration of acute respiratory infections
Mean duration in days of acute respiratory infections by supplementation group
Number of subjects with more than one acute respiratory infection episode
Number of subjects with more than one acute respiratory infection episode by supplementation group
Absenteeism
Number of subjects who reported absenteeism because of acute respiratory infections, by supplementation group
Episode-related medication
Number of subjects who reported episode-related medication by supplementation group
Fasting glucose
Changes in fasting glucose (final vs initial)
Uric acid
Changes in uric acid (final vs initial)
Blood urea nitrogen
Changes in blood urea nitrogen (final vs initial)
Creatinine
Changes in creatinine (final vs initial)
Cholesterol
Changes in cholesterol (final vs initial)
Triglycerides
Changes in triglycerides (final vs initial)
Number of acute respiratory infections
Number of acute respiratory infections episodes by supplementation group.

Full Information

First Posted
August 4, 2014
Last Updated
August 5, 2014
Sponsor
Omnilife Manufactura, SA de CV
Collaborators
University of Guadalajara
search

1. Study Identification

Unique Protocol Identification Number
NCT02210156
Brief Title
Effects of a Supplement on Acute Respiratory Infections
Official Title
Effects of a Dietary Supplement on the Incidence of Acute Respiratory Infections in Susceptible Adults
Study Type
Interventional

2. Study Status

Record Verification Date
August 2014
Overall Recruitment Status
Completed
Study Start Date
January 2012 (undefined)
Primary Completion Date
April 2012 (Actual)
Study Completion Date
April 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Omnilife Manufactura, SA de CV
Collaborators
University of Guadalajara

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to determine whether the consumption of a nutritional supplement with micronutrients and herbal extracts has an effect on the incidence of acute respiratory infections in susceptible adults. Our hypothesis is that subjects who consume the nutritional supplement will have a lower incidence and duration of acute respiratory infections in comparison with the placebo group.
Detailed Description
We conducted a randomized, parallel, double-blind, placebo-controlled, 90-day clinical trial from January to April, 2012. All staff who worked at the Omnilife's Entrepreneur Support Department (CREO by its initials in Spanish) were invited to participate. This department within Omnilife has a high incidence of acute respiratory infections (ARI) as reported internally by the company's medical service (accounting for 55% of doctor visits within the department in 2010) and hence, they represent a high number of individuals susceptible to ARI. We held a preliminary session with the department's entire staff to explain the procedures; we asked subjects interested to participate in the study to sign an informed consent form and fill a clinical history. The latter included an assessment of stress, using the Perceived Stress Scale (in which higher scores indicate higher levels of stress), and physical activity, using the International Physical Activity Questionnaire or IPAQ (in which physical activity is categorized in three levels: light, moderate and vigorous). In a second session the same week, participants visited the company's medical service for measurements of their weight and height (in accordance with the International Society for the Advancement of Kinanthropometry or ISAK standards), control laboratory tests and a medical examination to rule out the presence of infections. Weight measurements were taken using a Tanita BC553 Ironman Inner Scan Body Fat Scale (capacity of 150 kg, accuracy to 0.1 kg). Height measurements were made using a Seca 206 Stadiometer (accuracy to 0.1 cm, measuring range to 220 cm). Both measurements were performed by a two certified and standardized anthropometrists. Body mass index (BMI) was subsequently calculated using both variables as follows: BMI = weight in kg/(height in m)2. The medical examination was performed by the attending physician and a nurse. It consisted of an assessment of vital signs following procedures described in the literature and a physical examination of bodily organs and systems. Temperature was measured using a Microlife MT 1931 digital thermometer (measuring range from 32 to 43.9°C, accuracy to 0.1°C). Heart and respiratory rates were measured using a 3M Littmann Classic II S.E. stethoscope. Blood pressure readings were taken using a 3M Littmann Classic II S.E. stethoscope and an Aneroid Sphygmomanometer ce0483 (18-300 mmHg measurement range, accuracy to 2 mmHg). Laboratory tests were conducted with the support of an external laboratory (Instituto Diagnostico Especializado Arboledas, IDEA by its initials in Spanish). Included were a blood test of six items (fasting glucose, uric acid, creatinine, blood urea nitrogen, cholesterol and triglycerides) analyzed by the spectrophotometric method, a complete blood count with a flow cytometry/microscopy analysis of platelets, and a spectroscopy analysis to assess liver function. Subjects of laboratory analyses were tested after a 12-hour fast. This laboratory has obtained quality control certification from the Quality Assurance for Laboratories Program (PACAL) and the Internal Evaluation Quality Program (PREVECAL). In addition, its staff is certified in clinical diagnosis by the National Association of Clinical Chemists (CONAQUIC). Subjects who met inclusion criteria were randomly assigned to two groups: one which received the supplement (n=30), and a control group who received a placebo, which consisted in a mixture of maltodextrins, colors and flavors. Every day two dietitians prepared the products, who then gave the prepared products to two different supervisors who in turn gave the product to each participant for consumption. The supervisors recorded product administration and consumption for each participant on a control form. Simultaneously, each week the supervisors provided each participant with an ARI symptom and side effect diary to be filled in daily (indicating whether or not the symptom in question had presented). Participants delivered the supervisors their filled-in diaries the following week. Subjects were also requested not to self-medicate in the event they should feel any of the symptoms and to notify the principal researcher and attending physician, who would make a clinical assessment to confirm the presence or absence of ARI and provide any needed medical treatment. In such cases, participants were not to be excluded from the study, but treatment provided to them was documented. At the end of the supplementation period, the initial assessments were performed again. Subjects were also asked about their perceptions of their own health at that time compared to how they felt at the beginning of the study. Quantitative variables are expressed as mean (SD). Qualitative variables are expressed as frequency (%). Fisher's exact test was used to compare distribution percentages of qualitative variables between groups and to compare the total proportion of ill subjects across intervention groups using intent-to-treat and per-population concepts. The risk ratio and the risk difference were also calculated for episodes of ARI. To compare the average of quantitative variables between treatments, the Mann-Whitney U test was used. Statistical analyzes were run using the SPSS program version 10 for Windows and Open Epi version 3.01; p<0.05 was considered as significant.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Respiratory Tract Infection
Keywords
Respiratory tract infection, Incidence, Dietary supplements, Micronutrients, Plant extracts

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
45 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Two envelopes of the product in 240 ml of water in a disposable cup, 90 days of actual consumption.
Arm Title
Omniplus Supreme
Arm Type
Experimental
Arm Description
Two envelopes of the product in 240 ml of water in a disposable cup, 90 days of actual consumption.
Intervention Type
Dietary Supplement
Intervention Name(s)
Omniplus Supreme
Other Intervention Name(s)
Food supplement with micronutrients and plant extracts
Intervention Description
Two dietitians prepared the products (one preparer per product) by dissolving two envelopes of 20 ml of the product in 240 ml of water in a disposable cup, every day from Monday to Saturday during the intervention period (90 days of actual consumption). In order to maintain blinding, these dietitians then gave the prepared cups to two different supervisors who in turn gave the product to each participant for consumption (once-daily doses). The preparation and delivery of the product was carried out during two work shifts (morning and afternoon), depending on each participants work schedule. The supervisors recorded product administration and consumption for each participant on a control form.
Intervention Type
Other
Intervention Name(s)
Placebo
Intervention Description
A product with maltodextrins, flavors and colorants without vitamins, minerals and plant extracts. Two dietitians prepared the products (one preparer per product) by dissolving two envelopes of 20 ml of the product in 240 ml of water in a disposable cup, every day from Monday to Saturday during the intervention period (90 days of actual consumption). In order to maintain blinding, these dietitians then gave the prepared cups to two different supervisors who in turn gave the product to each participant for consumption (once-daily doses). The preparation and delivery of the product was carried out during two work shifts (morning and afternoon), depending on each participants work schedule. The supervisors recorded product administration and consumption for each participant on a control form.
Primary Outcome Measure Information:
Title
Incidence of acute respiratory infections
Description
Number of subjects with at least one episode of acute respiratory infection according to supplementation group.
Time Frame
90 days
Secondary Outcome Measure Information:
Title
Mean episodes of acute respiratory infections
Description
Mean episodes of acute respiratory infections by supplementation group
Time Frame
90 days
Title
Mean duration of acute respiratory infections
Description
Mean duration in days of acute respiratory infections by supplementation group
Time Frame
90 days
Title
Number of subjects with more than one acute respiratory infection episode
Description
Number of subjects with more than one acute respiratory infection episode by supplementation group
Time Frame
90 days
Title
Absenteeism
Description
Number of subjects who reported absenteeism because of acute respiratory infections, by supplementation group
Time Frame
90 days
Title
Episode-related medication
Description
Number of subjects who reported episode-related medication by supplementation group
Time Frame
90 days
Title
Fasting glucose
Description
Changes in fasting glucose (final vs initial)
Time Frame
90 days
Title
Uric acid
Description
Changes in uric acid (final vs initial)
Time Frame
90 days
Title
Blood urea nitrogen
Description
Changes in blood urea nitrogen (final vs initial)
Time Frame
90 days
Title
Creatinine
Description
Changes in creatinine (final vs initial)
Time Frame
90 days
Title
Cholesterol
Description
Changes in cholesterol (final vs initial)
Time Frame
90 days
Title
Triglycerides
Description
Changes in triglycerides (final vs initial)
Time Frame
90 days
Title
Number of acute respiratory infections
Description
Number of acute respiratory infections episodes by supplementation group.
Time Frame
90 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy adult subjects (without active respiratory infections, or without diseases that compromise immune system) Who presented no abnormalities in their laboratory tests (active infections, immunosuppression, renal or hepatic impairment) Who did not take drugs that affect the immune system (anti-inflammatory drugs, antibiotics, steroids). Exclusion Criteria: Subjects with active acute respiratory infections. Subjects with chronic respiratory disease requiring treatment other than bronchodilators at the time of assessment. Subjects with diseases affecting the immune system (autoimmune illness, diabetes, etc.) Pregnant women or currently nursing. Subjects with cardiovascular disorders (uncontrolled hypertension) or neurological disorders (epilepsy). Subjects with allergies to any components of the products. Subjects with low treatment adherence (less than 80%).
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
María F. Bernal-Orozco, Ph.D.
Organizational Affiliation
Omnilife Manufactura, SA de CV
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Margarita Posada-Falomir, B.Sc.(Nutr.)
Organizational Affiliation
Omnilife Manufactura, SA de CV
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Rafael Ortega-Orozco, M.D.
Organizational Affiliation
Omnilife Manufactura, SA de CV
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Elvia Silva-Villanueva, M.Sc.(O.H).
Organizational Affiliation
Omnilife Manufactura, SA de CV
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Gabriela Macedo-Ojeda, Ph.D.
Organizational Affiliation
University of Guadalajara
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Yolanda F. Marquez-Sandoval, Ph.D.
Organizational Affiliation
University of Guadalajara
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Barbara Vizmanos-Lamotte, M.D., Ph.D
Organizational Affiliation
University of Guadalajara
Official's Role
Principal Investigator
Facility Information:
Facility Name
Omnilife
City
Guadalajara
State/Province
Jalisco
ZIP/Postal Code
44500
Country
Mexico

12. IPD Sharing Statement

Citations:
PubMed Identifier
16253889
Citation
Eccles R. Understanding the symptoms of the common cold and influenza. Lancet Infect Dis. 2005 Nov;5(11):718-25. doi: 10.1016/S1473-3099(05)70270-X.
Results Reference
background
PubMed Identifier
12495459
Citation
Calder PC, Kew S. The immune system: a target for functional foods? Br J Nutr. 2002 Nov;88 Suppl 2:S165-77. doi: 10.1079/BJN2002682.
Results Reference
background
PubMed Identifier
21166296
Citation
Manoharan A, Winter J. Tackling upper respiratory tract infections. Practitioner. 2010 Nov;254(1734):25-8, 2-3.
Results Reference
background
PubMed Identifier
17726308
Citation
Wintergerst ES, Maggini S, Hornig DH. Contribution of selected vitamins and trace elements to immune function. Ann Nutr Metab. 2007;51(4):301-23. doi: 10.1159/000107673. Epub 2007 Aug 28.
Results Reference
background
PubMed Identifier
17549893
Citation
Ramirez MT, Hernandez RL. Factor structure of the Perceived Stress Scale (PSS) in a sample from Mexico. Span J Psychol. 2007 May;10(1):199-206. doi: 10.1017/s1138741600006466.
Results Reference
background
PubMed Identifier
16756533
Citation
Stephen AI, Avenell A. A systematic review of multivitamin and multimineral supplementation for infection. J Hum Nutr Diet. 2006 Jun;19(3):179-90. doi: 10.1111/j.1365-277X.2006.00694.x.
Results Reference
background
PubMed Identifier
19961353
Citation
Goyal SK, Samsher, Goyal RK. Stevia (Stevia rebaudiana) a bio-sweetener: a review. Int J Food Sci Nutr. 2010 Feb;61(1):1-10. doi: 10.3109/09637480903193049.
Results Reference
background
PubMed Identifier
21694984
Citation
Gohil KJ, Patel JA, Gajjar AK. Pharmacological Review on Centella asiatica: A Potential Herbal Cure-all. Indian J Pharm Sci. 2010 Sep;72(5):546-56. doi: 10.4103/0250-474X.78519.
Results Reference
background
PubMed Identifier
17296677
Citation
Cumashi A, Ushakova NA, Preobrazhenskaya ME, D'Incecco A, Piccoli A, Totani L, Tinari N, Morozevich GE, Berman AE, Bilan MI, Usov AI, Ustyuzhanina NE, Grachev AA, Sanderson CJ, Kelly M, Rabinovich GA, Iacobelli S, Nifantiev NE; Consorzio Interuniversitario Nazionale per la Bio-Oncologia, Italy. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology. 2007 May;17(5):541-52. doi: 10.1093/glycob/cwm014. Epub 2007 Feb 12.
Results Reference
background
PubMed Identifier
19500070
Citation
Panossian A, Wikman G. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol. 2009 Sep;4(3):198-219. doi: 10.2174/157488409789375311. Epub 2009 Sep 1.
Results Reference
background
PubMed Identifier
17125579
Citation
Karkos PD, Leong SC, Arya AK, Papouliakos SM, Apostolidou MT, Issing WJ. 'Complementary ENT': a systematic review of commonly used supplements. J Laryngol Otol. 2007 Aug;121(8):779-82. doi: 10.1017/S002221510600449X. Epub 2006 Nov 24.
Results Reference
background
PubMed Identifier
21173411
Citation
Barrett B, Brown R, Rakel D, Mundt M, Bone K, Barlow S, Ewers T. Echinacea for treating the common cold: a randomized trial. Ann Intern Med. 2010 Dec 21;153(12):769-77. doi: 10.7326/0003-4819-153-12-201012210-00003.
Results Reference
background
PubMed Identifier
9250133
Citation
Chandra RK. Nutrition and the immune system: an introduction. Am J Clin Nutr. 1997 Aug;66(2):460S-463S. doi: 10.1093/ajcn/66.2.460S.
Results Reference
background
PubMed Identifier
11781377
Citation
Field CJ, Johnson IR, Schley PD. Nutrients and their role in host resistance to infection. J Leukoc Biol. 2002 Jan;71(1):16-32.
Results Reference
background
PubMed Identifier
23326930
Citation
Rosler D, Fuchs N, Markolin G, Edler B, Kuklinski B, Kastenbauer T. [Reduction of influenza-like infections by a phytoextract-vitamin-combination: a randomized, double-blind, placebo-controlled study]. MMW Fortschr Med. 2012 Dec 17;154 Suppl 4:115-22. German.
Results Reference
background
PubMed Identifier
21859655
Citation
Liu Y, Jing H, Wang J, Zhang R, Zhang Y, Zhang Y, Xu Q, Yu X, Xue C. Micronutrients decrease incidence of common infections in type 2 diabetic outpatients. Asia Pac J Clin Nutr. 2011;20(3):375-82.
Results Reference
background
PubMed Identifier
15126020
Citation
Linday LA, Dolitsky JN, Shindledecker RD. Nutritional supplements as adjunctive therapy for children with chronic/recurrent sinusitis: pilot research. Int J Pediatr Otorhinolaryngol. 2004 Jun;68(6):785-93. doi: 10.1016/j.ijporl.2004.01.009.
Results Reference
background
PubMed Identifier
15562899
Citation
Linday LA, Shindledecker RD, Tapia-Mendoza J, Dolitsky JN. Effect of daily cod liver oil and a multivitamin-mineral supplement with selenium on upper respiratory tract pediatric visits by young, inner-city, Latino children: randomized pediatric sites. Ann Otol Rhinol Laryngol. 2004 Nov;113(11):891-901. doi: 10.1177/000348940411301108.
Results Reference
background
PubMed Identifier
14985222
Citation
Penny ME, Marin RM, Duran A, Peerson JM, Lanata CF, Lonnerdal B, Black RE, Brown KH. Randomized controlled trial of the effect of daily supplementation with zinc or multiple micronutrients on the morbidity, growth, and micronutrient status of young Peruvian children. Am J Clin Nutr. 2004 Mar;79(3):457-65. doi: 10.1093/ajcn/79.3.457.
Results Reference
background
PubMed Identifier
17299460
Citation
Begin F, Santizo MC, Peerson JM, Torun B, Brown KH. Effects of bovine serum concentrate, with or without supplemental micronutrients, on the growth, morbidity, and micronutrient status of young children in a low-income, peri-urban Guatemalan community. Eur J Clin Nutr. 2008 Jan;62(1):39-50. doi: 10.1038/sj.ejcn.1602682. Epub 2007 Feb 14.
Results Reference
background
PubMed Identifier
12169075
Citation
Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA. 2002 Aug 14;288(6):715-21. doi: 10.1001/jama.288.6.715.
Results Reference
background
PubMed Identifier
16081445
Citation
Avenell A, Campbell MK, Cook JA, Hannaford PC, Kilonzo MM, McNeill G, Milne AC, Ramsay CR, Seymour DG, Stephen AI, Vale LD. Effect of multivitamin and multimineral supplements on morbidity from infections in older people (MAVIS trial): pragmatic, randomised, double blind, placebo controlled trial. BMJ. 2005 Aug 6;331(7512):324-9. doi: 10.1136/bmj.331.7512.324.
Results Reference
background
PubMed Identifier
21387013
Citation
Croci DO, Cumashi A, Ushakova NA, Preobrazhenskaya ME, Piccoli A, Totani L, Ustyuzhanina NE, Bilan MI, Usov AI, Grachev AA, Morozevich GE, Berman AE, Sanderson CJ, Kelly M, Di Gregorio P, Rossi C, Tinari N, Iacobelli S, Rabinovich GA, Nifantiev NE; Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO), Italy. Fucans, but not fucomannoglucuronans, determine the biological activities of sulfated polysaccharides from Laminaria saccharina brown seaweed. PLoS One. 2011 Feb 28;6(2):e17283. doi: 10.1371/journal.pone.0017283.
Results Reference
background
PubMed Identifier
10944478
Citation
Erickson KL, Medina EA, Hubbard NE. Micronutrients and innate immunity. J Infect Dis. 2000 Sep;182 Suppl 1:S5-10. doi: 10.1086/315922.
Results Reference
background
PubMed Identifier
17182688
Citation
Lofgren E, Fefferman NH, Naumov YN, Gorski J, Naumova EN. Influenza seasonality: underlying causes and modeling theories. J Virol. 2007 Jun;81(11):5429-36. doi: 10.1128/JVI.01680-06. Epub 2006 Dec 20. No abstract available.
Results Reference
background
PubMed Identifier
21322286
Citation
Nahas R, Balla A. Complementary and alternative medicine for prevention and treatment of the common cold. Can Fam Physician. 2011 Jan;57(1):31-6.
Results Reference
background
PubMed Identifier
21506934
Citation
Puertollano MA, Puertollano E, de Cienfuegos GA, de Pablo MA. Dietary antioxidants: immunity and host defense. Curr Top Med Chem. 2011;11(14):1752-66. doi: 10.2174/156802611796235107.
Results Reference
background
Citation
Gestal-Otero JJ, Takkouche B, Blasco-Huelva P. Infecciones respiratorias agudas. Gripe. En: Piédrola-Gil G, editor. 1oa ed. Medicina preventiva y salud pública. Barcelona: Masson; 2001. p. 491-505
Results Reference
background
PubMed Identifier
6668417
Citation
Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983 Dec;24(4):385-96. No abstract available.
Results Reference
background
Citation
International Physical Activity Questionnaire [Web site]; 2005 [access november 4th 2011]. IPAQ Research Committee. Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ). Short and long forms. Available in: http://www.ipaq.ki.se/scoring.pdf.
Results Reference
background
PubMed Identifier
12900694
Citation
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003 Aug;35(8):1381-95. doi: 10.1249/01.MSS.0000078924.61453.FB.
Results Reference
background
Citation
Marfell-Jomes M, Olds T, Stewart A, Carter L. Estándares internacionales para la evaluación antropométrica. Revisión 2008. South Africa: Sociedad Internacional para el Avance de la Cineantropometría; 2008.
Results Reference
background
Citation
World Health Organization [Web site]. Geneva: The Organization; 2006 [updated november 11th 2011; access november 11th 2011]. BMI classification. Available in: http://apps.who.int/bmi/index.jsp?introPage=intro_3.html.
Results Reference
background
Citation
Vizmanos B, Bernal MF. Signos vitales. In: López-Uriarte P, Hunot C, Altamirano M, Macedo G, Vizmanos B, editors. Manual de prácticas de evaluación del estado nutricio. 1st ed. Guadalajara: La noche; 2007. p. 25-30.
Results Reference
background
Citation
Gupta S, Rajauria G, Sbu-Ghannam N. Study of the microbial diversity and antimicrobial properties of Irish edible brown seaweeds. Int J Food Sci Technol. 2010;45:482-9.
Results Reference
background
Citation
Jensen GS, Ginsberg DJ, Huerta P, Citton M, Drapeau C. Consumption of Aphanizomenon flos-aquae has rapid effects on the circulation and function of immune cells in humans. A novel approach to nutritional mobilization of the immune system. JANA 2000;2:50-8.
Results Reference
background
Citation
Castelloti C. Algas. Su uso terapéutico y nutricional. 1st ed. Madrid: Editorial Dilema; 2008.
Results Reference
background
PubMed Identifier
17593956
Citation
Luabeya KK, Mpontshane N, Mackay M, Ward H, Elson I, Chhagan M, Tomkins A, Van den Broeck J, Bennish ML. Zinc or multiple micronutrient supplementation to reduce diarrhea and respiratory disease in South African children: a randomized controlled trial. PLoS One. 2007 Jun 27;2(6):e541. doi: 10.1371/journal.pone.0000541.
Results Reference
background
Citation
McNair F, Heuchert JWP. Manual for the profile of mood states. San Diego (CA): Educational and Industrical Testing Service; 1971.
Results Reference
background
Citation
Mills S, Bone K. The essential guide to herbal safety. 1st ed. Philadelphia: Elsevier; 2005.
Results Reference
background
PubMed Identifier
17922955
Citation
Maggini S, Wintergerst ES, Beveridge S, Hornig DH. Selected vitamins and trace elements support immune function by strengthening epithelial barriers and cellular and humoral immune responses. Br J Nutr. 2007 Oct;98 Suppl 1:S29-35. doi: 10.1017/S0007114507832971.
Results Reference
background

Learn more about this trial

Effects of a Supplement on Acute Respiratory Infections

We'll reach out to this number within 24 hrs